Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review.

Han VX, Patel S, Jones HF, Nielsen TC, Mohammad SS, Hofer MJ, Gold W, Brilot F, Lain SJ, Nassar N, Dale RC. · 2021

Read Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review. by Han VX, Patel S, Jones HF, Nielsen TC, Mohammad SS, Hofer MJ, Gold W, Brilot F, Lain SJ, Nassar N, Dale RC. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7820474.txt.

Introduction

Han and co-authors review whether inflammation in pregnancy links to brain development disorders in children. A mother's immune activation may shape the growing brain. Both brief and long-lasting inflammation count here. Strong lab evidence backs the idea. Human evidence is mixed.

The team found 32 meta-analyses and 26 single studies. States tied to autism in the mother include obesity and diabetes in pregnancy. High blood pressure, pollution, stress, and infection also appear. ADHD links include obesity, smoking, and low income. Tourette syndrome links include low income, depression, and autoimmune disease. The authors call for work on combined risks. They also urge search for ways to prevent harm.

Catalog record

CREATORHan VX, Patel S, Jones HF, Nielsen TC, Mohammad SS, Hofer MJ, Gold W, Brilot F, Lain SJ, Nassar N, Dale RC.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE53 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7820474

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review By Velda X Han, Shrujna Patel, Hannah F Jones, Timothy C Nielsen, Shekeeb S Mohammad, Markus J Hofer, Wendy Gold, Fabienne Brilot, Samantha J Lain, Natasha Nassar, Russell C Dale Published in: Translational Psychiatry DOI: 10.1038/s41398-021-01198-w ABSTRACT Abstract Inflammation is increasingly recognized as a cause or consequence of common problems of humanity including obesity, stress, depression, pollution and disease states such as autoimmunity, asthma, and infection. Maternal immune activation (MIA), triggered by both acute and systemic chronic inflammation, is hypothesized to be one of the mechanisms implicated in the pathogenesis of neurodevelopmental disorders (NDD). Although there is substantial preclinical evidence to support the MIA hypothesis, the human evidence is disparate. We performed a systematic review on human studies examining associations between maternal inflammatory states and offspring NDDs (autism spectrum disorder- ASD, attention deficit hyperactivity disorder-ADHD, Tourette syndrome-TS). 32 meta-analyses and 26 additional individual studies were identified. Maternal states associated with ASD include obesity, gestational diabetes mellitus, pre-eclampsia, pollution, stress, depression, autoimmune diseases, and infection. Maternal states associated with ADHD include obesity, pre-eclampsia, smoking, low socioeconomic status (SES), stress, autoimmune disease, and asthma. Maternal states associated with TS include low SES, depression, and autoimmune diseases. Diverse maternal inflammatory states in pregnancy are associated with common offspring NDDs. Given the increased prevalence of NDDs, there is urgent need to explore relative and cumulative maternal risk factors and disease mechanisms. Defining preventable risk factors in high-risk pregnancies could mitigate the expression and severity of NDDs. Subject terms: Autism spectrum disorders, ADHD INTRODUCTION Systemic chronic inflammation (SCI) is implicated in many common disease states encountered throughout life including cardiovascular diseases, chronic kidney disease, autoimmune diseases, cancer, depression, and neurodegenerative diseases1. The overarching characteristic of SCI is a persistent, sterile, non-resolving inflammation that increases with age1. This contrasts with acute inflammation that is usually infection provoked and results in short-term, high-grade inflammation1. There is increasing evidence that environmental and lifestyle factors including obesity, unhealthy diet, psychosocial stress, physical inactivity, disturbed sleep, microbial dysbiosis, and exposure to toxicants like smoke and pollution, collectively known as the exposome, contribute to SCI1. Parental SCI and disease risk may be transmitted to their offspring via a “DNA inflammatory signature” through epigenetic alterations, resulting in increased risk of inflammatory diseases in the next generation1. Furthermore, maternal SCI in pregnancy, which is a sensitive window of immune vulnerability, may adversely affect programming of the fetal immune, metabolic and neurological systems with long-lasting effects into adulthood1,2. Dynamic genetic, epigenetic, and environmental interactions play a major role in supporting and shaping neural networks in the brain throughout life3. Preclinical data show that early life environmental disruptions to the developing central nervous system can result in negative consequences on neurobehavioral, cognitive, and mental health outcomes in the individual4. During embryogenesis and fetal growth, a complex network of neural circuits is being established through glia and neuron proliferation, migration, programmed cell death, formation of synapses, and myelination3. Ill-timed disruption of the in utero environment by maternal neuroendocrine, autonomic nervous system, inflammatory, neurotropic, and metabolic factors have been shown to affect fetal neurodevelopment4. Initial epidemiological studies established a link between infection during pregnancy and increased risk of schizophrenia and autism spectrum disorders in children, and animal models have since discovered that the neurobehavioral sequelae result from the maternal immune response to the pathogen rather than direct invasion of the virus1,4,5. Thus, maternal acute inflammation during pregnancy is posited to play a key role in the pathogenesis of neurobehavioral and psychiatric disorders, amongst other pathways4. However, the impacts of maternal SCI in pregnancy on fetal neuro-programming is less studied or established. Although the initial interest was centered around infection-triggered maternal immune activation (MIA), there is emerging evidence that maternal disorders associated with SCI can also trigger an abnormal immune response during pregnancy resulting in increased neurodevelopmental risks in offspring1. Multiple factors, which have in common SCI, including obesity, gestational diabetes (GDM), pre-eclampsia, smoking, exposure to pollution, low socioeconomic status (SES), depression, stress, autoimmune diseases, asthma and infection have been proposed to contribute to maternal immune activation (Fig. 1)1. Animal models have demonstrated maternal factors including obesity, stress, exposure to pollution, asthma, and infection, result in behavioral and transcriptional changes in offspring, through cytokine signaling mechanisms mediated by the placenta4,6–8. However, the human evidence is disparate and limited to individual inflammatory states with specific neurodevelopmental disorders. [Figure: Maternal immune activation, triggered by acute and systemic chronic inflammation, is proposed to affect fetal neurodevelopment, through inflammatory and epigenetic mechanisms.Common maternal disease and environmental factors including obesity, gestational diabetes, pre-eclampsia, smoking, pollution, low socioeconomic status, depression, psychosocial stress, autoimmune diseases and asthma are implicated in systemic chronic inflammation. In addition, infection is involved in acute inflammation. These maternal inflammatory states play a key role in immune activation during pregnancy through the placenta and immature blood-brain barrier to cause dysfunction in the developing fetal brain and prime the child to be susceptible to future hits through microglia activation and epigenetic alterations, manifesting a spectrum of diverse neurodevelopmental outcomes with varied expression and progression.] In this systematic review, we focus on the associations between maternal inflammation in pregnancy, which are associated with acute inflammation or SCI, and common neurodevelopmental disorders in children, namely autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), and Tourette syndrome (TS). Maternal infection during pregnancy was chosen as a marker for acute inflammation. In this review, we included maternal factors known to contribute to SCI such as obesity, psychosocial stress, low socioeconomic status, exposure to smoking and pollution, and human disorders known to be associated with SCI such as autoimmune disorders, asthma, depression, pre-eclampsia, and gestational diabetes. We did not include other factors in the exposome including diet, sleep, exercise, microbiome alterations, or exposure to other toxicants, as they are difficult to quantify objectively. In this review, we group these 11 risk factors as “maternal inflammatory states”. Although there have been multiple epidemiological studies linking individual maternal inflammatory states to neurodevelopmental disorders, a collective review has not been performed before. We provide evidence in human studies to support the hypothesis that a broad spectrum of maternal inflammatory states is associated with an increased risk of diverse neurodevelopmental disorders in offspring. We also discuss potential underlying mechanisms and offer recommendations for future studies. MATERIALS AND METHODS In this systematic review, a literature search on PubMed and Embase databases was performed to identify studies. We describe the search strategy (Supplementary Table 1), study eligibility (Supplementary Table 1), search terms (Supplementary Table 2), and definitions of maternal inflammatory states (Supplementary Table 3) separately. 408 meta-analyses were identified using the first search strategy and 32 meta-analyses were included in the review after removing duplicates, irrelevant studies, and assessing full-text articles (Fig. 2). Meta-analyses of an association between individual maternal inflammatory states and ASD (21 meta-analyses comprising 146 individual study results) or ADHD (14 meta-analyses comprising 126 individual study results) in offspring were included, however, no meta-analyses were found relating to maternal inflammatory states and TS. No meta-analyses investigated associations between maternal asthma and ASD or ADHD, low SES and ASD, or maternal infection and ADHD in offspring. [Figure: Study selection flow diagram of studies included

Read the complete text